R. Kent Jr McGaughy

Insider Reports History

Entity: Individual
Location: 500 Crescent Court, Suite 250, Dallas, TX
Signature: /s/ Sandeep Laumas, M.D. Attorney-in-Fact for R Kent Jr McGaughy
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by R. Kent Jr McGaughy:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
PROCEPT BioRobotics Corp	10%+ Owner	Common Stock	2.82M	$181M	$64.04	May 3, 2024	By White Tailed Ptarmigan, LP
PROCEPT BioRobotics Corp	10%+ Owner	Common Stock	554K	$35.5M	$64.04	May 3, 2024	By Lagos Trust
PROCEPT BioRobotics Corp	10%+ Owner	Common Stock	345K	$22.1M	$64.04	May 3, 2024	By Mallard Fund, L.P.
PROCEPT BioRobotics Corp	10%+ Owner	Common Stock	54K	$3.46M	$64.04	May 3, 2024	By Kestrel Fund, L.P.
PROCEPT BioRobotics Corp	10%+ Owner	Common Stock	4.52K	$290K	$64.04	May 3, 2024	Direct
Instil Bio, Inc.	Director	Stock Option (Right to Buy)	5K			Jun 13, 2024	Direct
Apollo Endosurgery, Inc.	Director, 10%+ Owner	Common Stock	0		$6.46	Apr 4, 2023	By Crested Crane, LP
Apollo Endosurgery, Inc.	Director, 10%+ Owner	Common Stock	0		$6.46	Apr 4, 2023	By Curlew Fund, LP
Apollo Endosurgery, Inc.	Director, 10%+ Owner	Common Stock	0		$6.46	Apr 4, 2023	By Kestrel Fund, LP
Apollo Endosurgery, Inc.	Director, 10%+ Owner	Common Stock	0		$6.46	Apr 4, 2023	By Killdeer Fund, LP
Apollo Endosurgery, Inc.	Director, 10%+ Owner	Common Stock	0		$6.46	Apr 4, 2023	By Mallard Fund, LP
Apollo Endosurgery, Inc.	Director, 10%+ Owner	Common Stock	0		$6.46	Apr 4, 2023	By Roadrunner Fund, LP
Apollo Endosurgery, Inc.	Director, 10%+ Owner	Stock Option (Right to Buy)	0		$8.86	Apr 4, 2023	Direct
REATA PHARMACEUTICALS INC	Director, 10%+ Owner	Class A common stock	0		$172.03	Sep 26, 2023	By Lagos Trust
REATA PHARMACEUTICALS INC	Director, 10%+ Owner	Class A common stock	0		$172.03	Sep 26, 2023	By Traweek Children's Trust
REATA PHARMACEUTICALS INC	Director, 10%+ Owner	Class A common stock	0		$172.03	Sep 26, 2023	Direct
REATA PHARMACEUTICALS INC	Director, 10%+ Owner	Class A common stock	0		$172.03	Sep 26, 2023	Indirect
REATA PHARMACEUTICALS INC	Director, 10%+ Owner	Class B common stock	0		$172.03	Sep 26, 2023	By Lagos Trust
REATA PHARMACEUTICALS INC	Director, 10%+ Owner	Class B common stock	0		$172.03	Sep 26, 2023	By Traweek Children's Trust
REATA PHARMACEUTICALS INC	Director, 10%+ Owner	Class B common stock	0		$172.03	Sep 26, 2023	Direct
REATA PHARMACEUTICALS INC	Director, 10%+ Owner	Class B common stock	0		$172.03	Sep 26, 2023	Indirect
REATA PHARMACEUTICALS INC	Director, 10%+ Owner	Stock Option (right to buy)	0			Sep 26, 2023	Direct

Previous1Next

Showing 1 to 22 of 22 entries

Insider Reports Filed by R. Kent Jr McGaughy

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
TIL	Instil Bio, Inc.	Jun 13, 2024	1	$0	4	Jun 13, 2024	Director
PRCT	PROCEPT BioRobotics Corp	May 3, 2024	1	$0	4	May 7, 2024	10%+ Owner
RETA	REATA PHARMACEUTICALS INC	Sep 26, 2023	25	$0	4	Sep 26, 2023	Director, 10%+ Owner
TIL	Instil Bio, Inc.	Jun 14, 2023	1	$0	4	Jan 10, 2024	Director
RETA	REATA PHARMACEUTICALS INC	Jun 7, 2023	2	$120K	4	Jun 9, 2023	Director, 10%+ Owner
APEN	Apollo Endosurgery, Inc.	Apr 4, 2023	7	$0	4	Apr 4, 2023	Director, 10%+ Owner
RETA	REATA PHARMACEUTICALS INC	Mar 3, 2023	1	$0	4	Mar 7, 2023	Director, 10%+ Owner
APEN	Apollo Endosurgery, Inc.	Dec 28, 2022	6	$3.75	4	Dec 30, 2022	Director, 10%+ Owner
PRCT	PROCEPT BioRobotics Corp	Dec 5, 2022	1	$0	4	Dec 7, 2022	10%+ Owner
PRCT	PROCEPT BioRobotics Corp	Nov 14, 2022	1	$0	4	Nov 16, 2022	10%+ Owner
PRCT	PROCEPT BioRobotics Corp	Sep 9, 2022	1	$0	4	Sep 13, 2022	10%+ Owner
PRCT	PROCEPT BioRobotics Corp	Sep 6, 2022	1	$0	4	Sep 8, 2022	10%+ Owner
APEN	Apollo Endosurgery, Inc.	Jun 14, 2022	1	$0	4	Jun 16, 2022	Director, 10%+ Owner
RETA	REATA PHARMACEUTICALS INC	Jun 8, 2022	2	$115K	4	Jun 10, 2022	Director, 10%+ Owner
TIL	Instil Bio, Inc.	May 20, 2022	1	$0	4	May 25, 2022	Director
TIL	Instil Bio, Inc.	Mar 15, 2022	1	$0	4	Mar 17, 2022	Director
RETA	REATA PHARMACEUTICALS INC	Jan 3, 2022	1	$6.44K	4	Jan 5, 2022	Director, 10%+ Owner
APEN	Apollo Endosurgery, Inc.	Oct 15, 2021	3	$5.3M	4	Oct 19, 2021	Director, 10%+ Owner
RETA	REATA PHARMACEUTICALS INC	Jun 10, 2021	2	$57.4K	4	Jun 14, 2021	Director, 10%+ Owner